Showing results (1571-1580 of 1,790) with videos related to

Sort By:
Pageof 179
Bone Marrow Transplantation|November 29, 2016
Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndromeS-A Yahng, Y-W Jeon, J-H Yoon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 23, 2015
Long-term control of diabetes in immunosuppressed nonhuman primates (NHP) by the transplantation of adult porcine isletsJ S Shin, J M Kim, J S Kim, et al.
Bone Marrow Transplantation|December 16, 2014
Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALLM Kim, J Park, D-W Kim, et al.
Oncogene|March 23, 2011
IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signalsJ H Oh, M-C Cho, J-H Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2026
A Randomized Phase III Trial of Anthracyclines Followed by Taxane versus Taxane Plus Carboplatin as (Neo)Adjuvant Therapy in Patients with Triple-Negative Breast Cancer: KCSG BR 15-1 PEARLY TrialG M Kim, K H Jung, H C Jeung, et al.
Leukemia|January 17, 2017
The clonal origins of leukemic progression of myelodysplasiaT Kim, M S Tyndel, H J Kim, et al.
Clinical Genetics|October 10, 2015
Prevalence of type 5 familial hemophagocytic lymphohistiocytosis in Korea and novel mutations in STXBP2J Y Seo, K-O Lee, K-H Yoo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2012
Proteins involved in DNA damage response pathways and survival of stage I non-small-cell lung cancer patientsC M Choi, S C Yang, H J Jo, et al.
The Lancet. Infectious Diseases|February 27, 2025
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trialGhady Haidar, Steven Thomas, Paul Loubet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 5, 2010
Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patientsM K Kim, C Suh, D H Lee, et al.
Pageof 179